GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for N-methyl-L-tryptophan oxidase (A7ZZ17)

Analyse AlphaFold monomer V2.0 prediction for N-methyl-L-tryptophan oxidase (A7ZZ17) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A7ZZ17
Type
protein
Length
372 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x259588DFB096e6cFD5e57eb1eb2b366277d98BC6
Molecule
N-methyl-L-tryptophan oxidase
UniProt
A7ZZ17
Pockets
2 · best druggability 0.81

Structure

1 distinct chain · 29% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AN-methyl-L-tryptophan oxidaseprotein37229% helix, 31% strandA7ZZ17

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14710.810.8975empty
21000.370.7517empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.